Senseonics (SENS) CMO logs Form 4 tax-withholding on 6,058 RSU shares

Rhea-AI Filing Summary

Senseonics Holdings, Inc. director and Chief Medical Officer Francine Kaufman reported a tax-related share disposition tied to equity compensation. On this Form 4, 6,058 shares of common stock were withheld at $5.82 per share to cover withholding tax obligations upon the vesting of restricted stock units. After this withholding, Kaufman directly holds 117,890 shares of Senseonics common stock.

Insights

Equity compensation analyst

Routine tax withholding on RSU vesting; no open-market trade.

The filing shows 6,058 Senseonics common shares withheld at $5.82 per share to satisfy tax obligations triggered by restricted stock unit vesting. This is coded as an F transaction, which represents payment of tax liability by delivering securities.

Because this is issuer withholding rather than an open-market sale, it carries little informational value about the insider’s view of the stock. Following the withholding, Francine Kaufman directly holds 117,890 shares, indicating she retains a meaningful equity stake after this routine compensation-related event.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kaufman Francine

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	6,058	$5.82	$35K

Holdings After Transaction: Common Stock — 117,890 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withheld shares: 6,058 shares Withholding price: $5.82 per share Shares held after transaction: 117,890 shares +1 more

4 metrics

Tax-withheld shares 6,058 shares Shares withheld to cover RSU tax obligations

Withholding price $5.82 per share Implied value for tax-withheld shares

Shares held after transaction 117,890 shares Direct common stock holdings post-withholding

Tax-withholding transactions 1 transaction / 6,058 shares Summary of F-code tax-withholding activity

Key Terms

restricted stock units, withholding tax obligations, tax-withholding disposition, Form 4, +1 more

5 terms

restricted stock units financial

"upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

withholding tax obligations financial

"shares withheld to satisfy withholding tax obligations"

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 regulatory

"On this Form 4, 6,058 shares of common stock were withheld"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Chief Medical Officer financial

"officer_title": "Chief Medical Officer""

A chief medical officer is a senior executive responsible for overseeing the health and medical strategies within an organization, often in the healthcare or pharmaceutical sectors. They play a key role in guiding decisions related to medical research, product safety, and healthcare policies, which can impact a company's reputation and success. For investors, understanding the chief medical officer's role helps gauge how well a company manages medical risks and advances its healthcare goals.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kaufman Francine

(Last) (First) (Middle)

20451 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MARYLAND 20876

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Senseonics Holdings, Inc. [ SENS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		F(1)		6,058	D	$5.82	117,890	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

	/s/ Frederick T. Sullivan, Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did SENS Chief Medical Officer Francine Kaufman report?

Francine Kaufman reported a tax-withholding disposition, where 6,058 shares of Senseonics common stock were withheld to cover taxes due on restricted stock unit vesting. This is a routine equity compensation event, not an open-market purchase or sale of shares.

How many SENS shares were involved in Francine Kaufman’s latest Form 4 filing?

The Form 4 reports 6,058 shares of Senseonics common stock disposed of through withholding at $5.82 per share. These shares were retained by the company to satisfy Kaufman’s withholding tax obligations when her restricted stock units vested, rather than sold in the market.

Did Francine Kaufman sell SENS shares on the open market in this Form 4?

No, Kaufman did not conduct an open-market sale. The 6,058-share disposition is coded F, meaning shares were withheld by the issuer to pay tax obligations from RSU vesting. This type of transaction does not represent a discretionary sale decision by the insider.

How many SENS shares does Francine Kaufman hold after the reported tax withholding?

After the tax-withholding disposition, Francine Kaufman directly holds 117,890 shares of Senseonics common stock. This post-transaction balance reflects her remaining equity stake following the 6,058 shares withheld to satisfy withholding tax obligations upon restricted stock unit vesting.

What does transaction code F mean in the SENS Form 4 for Francine Kaufman?

Transaction code F indicates shares were disposed of to pay the exercise price or tax liability by delivering securities. In this case, 6,058 Senseonics shares were withheld to cover withholding tax obligations triggered when Kaufman’s restricted stock units vested, rather than sold on the open market.